TRIB2 Human Pre-designed siRNA Set A contains three designed siRNAs for TRIB2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRIB3 Human Pre-designed siRNA Set A contains three designed siRNAs for TRIB3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Trichlormethiazide (Standard) is the analytical standard of Trichlormethiazide. This product is intended for research and analytical applications. Trichlormethiazide is an orally active thiazide diuretic, with antihypertensive effect. Trichlormethiazide increases urine volume (UV), Na and K excretion and tends to improve the depressed creatinine clearance (CCRE) in acute renal failure rats model[1][2].

Trichostatin C is an inhibitor for histone deacetylase (HDAC), induces apoptosis and arrests cell cycle at G2/M phase, and exhibits anticancer activity against lung cancer and urothelial bladder cancer[1]. Trichostatin C induces differentation of Friend leukemic cells[2]. Trichostatin C exhibits antifungal activity[3].

Tricosanoyl-CoA triammonium is a very long-chain fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A (HY-128851) with the carboxy group of tricosanoic acid (HY-W009081). Tricosanoyl-CoA is functionally related to a tricosanoic acid. Tricosanoyl-CoA is a conjugate acid of a tricosanoyl-CoA(4-).

Tricyclic cytosine tC is a fluorescent base analogue that can be used as a fluorescent probe in nucleic acid-containing systems. The excitation wavelength is 385 nm and the emission wavelength is 505 nm[1][2].

Tricyclodecenyl acetate-13C2 is 13C labeled 2-Acetylthiazole.

Tridecanoyl-CoA triammonium, a coenzyme, is used as a primer[1].

Tridocosahexaenoylglycerol (TG-DHA) is an orally active dietary supplement that improves autoimmune encephalomyelitis in mice. Tridocosahexaenoylglycerol shows beneficial effects on neurodegenerative diseases and also improves macular function in diabetic retinopathy. Tridocosahexaenoylglycerol can be used for research on neurological diseases, inflammatory immune diseases, and metabolic diseases[1][2][3].

Triethylene glycol (Standard) is the analytical standard of Triethylene glycol. This product is intended for research and analytical applications. Triethylene glycol (PROTAC Linker 25) is a PEG-based PROTAC linker can be used in the synthesis of PROTACs[1].

Trifenagrel is a platelet aggregation inhibitor that inhibits the inducing effects of arachidonic acid (AA) and collagen. The ED50s of trifenagrel for inhibiting AA- and collagen-induced platelet aggregation in guinea pigs were 1.4 mg/kg and 9.4 mg/kg, respectively[1].

Trifenagrel is a platelet aggregation inhibitor that inhibits the inducing effects of arachidonic acid (AA) and collagen. The ED50s of trifenagrel for inhibiting AA- and collagen-induced platelet aggregation in guinea pigs were 1.4 mg/kg and 9.4 mg/kg, respectively[1].

Trifenagrel is a platelet aggregation inhibitor that inhibits the inducing effects of arachidonic acid (AA) and collagen. The ED50s of trifenagrel for inhibiting AA- and collagen-induced platelet aggregation in guinea pigs were 1.4 mg/kg and 9.4 mg/kg, respectively[1].

Trifenagrel is a platelet aggregation inhibitor that inhibits the inducing effects of arachidonic acid (AA) and collagen. The ED50s of trifenagrel for inhibiting AA- and collagen-induced platelet aggregation in guinea pigs were 1.4 mg/kg and 9.4 mg/kg, respectively[1].

Trifenagrel is a platelet aggregation inhibitor that inhibits the inducing effects of arachidonic acid (AA) and collagen. The ED50s of trifenagrel for inhibiting AA- and collagen-induced platelet aggregation in guinea pigs were 1.4 mg/kg and 9.4 mg/kg, respectively[1].

Trifloxystrobin (Standard) is the analytical standard of Trifloxystrobin. This product is intended for research and analytical applications. Trifloxystrobin (CGA 279202) is a type of fungicide. Trifloxystrobin has toxicity, antiparasitic activity and induce apoptosis, oxidative stress and DNA damage. Trifloxystrobin can be used for the reaesrch of fungal diseases[1][2][3][4][5].

Triheneicosanoin is a triacylglycerol containing heneicosanoic acid groups. Triheneicosanoin can be used as internal standard for the quantification of fatty acids in the milk samples[1].

Triiodothyronine sulfate is the main metabolite of thyroid hormone triiodothyronine (T3). Triiodothyronine is an active form of thyroid hormone, which binds to β1 thyroid hormone receptor (TRβ1), and activates its activity[1][2].

TRIL Human Pre-designed siRNA Set A contains three designed siRNAs for TRIL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Trilexium (TRX-E-009-1) is a third-generation of benzopyran structurally related to TRX-E-002-1 (HY-114250). Trilexium increases p21 protein expression and induces apoptosis. Trilexium depolymerizes microtubules. Trilexium shows broad anti-cancer activity[1][2].

Trilexium (TRX-E-009-1) is a third-generation of benzopyran structurally related to TRX-E-002-1 (HY-114250). Trilexium increases p21 protein expression and induces apoptosis. Trilexium depolymerizes microtubules. Trilexium shows broad anti-cancer activity[1][2].

Trilexium (TRX-E-009-1) is a third-generation of benzopyran structurally related to TRX-E-002-1 (HY-114250). Trilexium increases p21 protein expression and induces apoptosis. Trilexium depolymerizes microtubules. Trilexium shows broad anti-cancer activity[1][2].

Trilexium (TRX-E-009-1) is a third-generation of benzopyran structurally related to TRX-E-002-1 (HY-114250). Trilexium increases p21 protein expression and induces apoptosis. Trilexium depolymerizes microtubules. Trilexium shows broad anti-cancer activity[1][2].

Trilexium (TRX-E-009-1) is a third-generation of benzopyran structurally related to TRX-E-002-1 (HY-114250). Trilexium increases p21 protein expression and induces apoptosis. Trilexium depolymerizes microtubules. Trilexium shows broad anti-cancer activity[1][2].

Trilexium (TRX-E-009-1) is a third-generation of benzopyran structurally related to TRX-E-002-1 (HY-114250). Trilexium increases p21 protein expression and induces apoptosis. Trilexium depolymerizes microtubules. Trilexium shows broad anti-cancer activity[1][2].

TRIM10 Human Pre-designed siRNA Set A contains three designed siRNAs for TRIM10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRIM11 Human Pre-designed siRNA Set A contains three designed siRNAs for TRIM11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRIM13 Human Pre-designed siRNA Set A contains three designed siRNAs for TRIM13 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRIM14 Human Pre-designed siRNA Set A contains three designed siRNAs for TRIM14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRIM15 Human Pre-designed siRNA Set A contains three designed siRNAs for TRIM15 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRIM16 Human Pre-designed siRNA Set A contains three designed siRNAs for TRIM16 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRIM2 Human Pre-designed siRNA Set A contains three designed siRNAs for TRIM2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRIM21 Human Pre-designed siRNA Set A contains three designed siRNAs for TRIM21 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRIM22 Human Pre-designed siRNA Set A contains three designed siRNAs for TRIM22 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRIM23 Human Pre-designed siRNA Set A contains three designed siRNAs for TRIM23 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRIM24 Human Pre-designed siRNA Set A contains three designed siRNAs for TRIM24 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRIM25 Human Pre-designed siRNA Set A contains three designed siRNAs for TRIM25 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRIM26 Human Pre-designed siRNA Set A contains three designed siRNAs for TRIM26 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRIM27 Human Pre-designed siRNA Set A contains three designed siRNAs for TRIM27 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRIM28 Human Pre-designed siRNA Set A contains three designed siRNAs for TRIM28 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRIM29 Human Pre-designed siRNA Set A contains three designed siRNAs for TRIM29 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRIM3 Human Pre-designed siRNA Set A contains three designed siRNAs for TRIM3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRIM31 Human Pre-designed siRNA Set A contains three designed siRNAs for TRIM31 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRIM32 Human Pre-designed siRNA Set A contains three designed siRNAs for TRIM32 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.